Tempol attenuates atherosclerosis associated with metabolic syndrome via decreased vascular inflammation and NADPH-2 oxidase expression

Author: Cannizzo B.   Quesada I.   Militello R.   Amaya C.   Miatello R.   Cruzado M.   Castro C.  

Publisher: Informa Healthcare

ISSN: 1071-5762

Source: Free Radical Research, Vol.48, Iss.5, 2014-05, pp. : 526-533

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content